<VariationArchive RecordType="classified" VariationID="98127" VariationName="NM_002087.4(GRN):c.154del (p.Thr52fs)" VariationType="Deletion" Accession="VCV000098127" Version="6" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-03-05" DateCreated="2014-02-20" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="104019" VariationID="98127">
      <GeneList>
        <Gene Symbol="GRN" FullName="granulin precursor" GeneID="2896" HGNC_ID="HGNC:4601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44345302" stop="44353106" display_start="44345302" display_stop="44353106" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42422490" stop="42430469" display_start="42422490" display_stop="42430469" Strand="+" />
          </Location>
          <OMIM>138945</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002087.4(GRN):c.154del (p.Thr52fs)</Name>
      <CanonicalSPDI>NC_000017.11:44349439:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44349440" stop="44349440" display_start="44349440" display_stop="44349440" variantLength="1" positionVCF="44349439" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42426808" stop="42426808" display_start="42426808" display_stop="42426808" variantLength="1" positionVCF="42426807" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T52fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_661" sequenceAccession="LRG_661">
            <Expression>LRG_661:g.9319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_661t1" sequenceAccession="LRG_661t1">
            <Expression>LRG_661t1:c.154del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42426809del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42426809del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44349441del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44349441del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.9319del">
            <Expression>NG_007886.1:g.9319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.4" sequenceAccession="NM_002087" sequenceVersion="4" change="c.154del" MANESelect="true">
            <Expression>NM_002087.4:c.154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002078.1" sequenceAccession="NP_002078" sequenceVersion="1" change="p.Thr52fs">
            <Expression>NP_002078.1:p.Thr52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA225214" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
        <XRef Type="rs" ID="63751092" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002087.4(GRN):c.154del (p.Thr52fs) AND not provided" Accession="RCV000084429" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002087.4(GRN):c.154del (p.Thr52fs) AND GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" Accession="RCV002281920" Version="1">
        <ClassifiedConditionList TraitSetID="5202">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-26" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2014-02-20" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20142525</ID>
        </Citation>
        <DescriptionHistory Dated="2021-09-18">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5202" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="204368" SubmissionDate="2013-02-13" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="ADM_286" />
        <ClinVarAccession Accession="SCV000116565" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="VIB Department of Molecular Genetics, University of Antwerp" OrgID="500316" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42426809delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment Type="public">http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg18&amp;id=ADM_286</Comment>
        <SubmissionNameList>
          <SubmissionName>VIB_MOLGEN_ADFTDMDB_2008_3_21</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37668" SubmissionDate="2016-08-12" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138945.0017_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" title="GRN, 1-BP DEL, 154A_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" />
        <ClinVarAccession Accession="SCV000037668" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 7 affected members of a family with autosomal dominant inheritance of FTLD (607485), Kelley et al. (2010) identified a heterozygous 1-bp deletion (154delA) in exon 2 of the GRN gene, resulting in a frameshift and premature termination. Of 10 affected individuals, 6 presented with early amnestic symptoms resulting in initial clinical diagnoses of Alzheimer disease (AD; 104300) or amnestic mild cognitive impairment, and 3 with frontotemporal dementia; 1 had nonspecific dementia. Neuropathologic examination of 6 individuals showed FTLD with ubiquitin-positive neuronal cytoplasmic and intranuclear inclusions, even in those with an AD diagnosis. The mean age at onset was younger in the third generation (60.7 years) than in the second generation (75.8 years). Kelley et al. (2010) noted that the presentation in some individuals with GRN-related FTLD may include Alzheimer disease-like clinical features, particularly anterograde amnesia.</Attribute>
              <Citation>
                <ID Source="PubMed">20142525</ID>
              </Citation>
              <XRef DB="OMIM" ID="607485" Type="MIM" />
              <XRef DB="OMIM" ID="104300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <Name>GRN, 1-BP DEL, 154A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 154A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138945.0017" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3676298" SubmissionDate="2022-09-28" DateLastUpdated="2023-03-04" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="GDXSV:240838" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001874155" DateUpdated="2023-03-04" DateCreated="2021-09-19" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19649643, 28473694, 20142525, 16950801, 18543312, 19659892, 30009200)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:715923</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002087.2:c.154del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_132_20220928054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_39_20210915114944</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37668" TraitType="Disease" MappingType="Name" MappingValue="FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" MappingRef="Preferred">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3676298" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="204368" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

